These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 3884171)
21. Mutagenic activation of N-nitrosobis(2-oxopropyl)amine by pancreatic juice and assessment of its ductal tumorigenicity following intraductal administration in dogs. Kamano T; Mori Y; Suda K; Takahashi M; Uchida T; Takada T; Tsutsumi M; Konishi Y Int J Pancreatol; 1996 Aug; 20(1):51-7. PubMed ID: 8872524 [TBL] [Abstract][Full Text] [Related]
22. 3-Methoxy-4-aminoazobenzene, a unique carcinogenic aromatic amine as a substrate for cytochrome-P-450-mediated mutagenesis. Degawa M; Kojima M; Hashimoto Y Mutat Res; 1985; 152(2-3):125-9. PubMed ID: 3934534 [TBL] [Abstract][Full Text] [Related]
23. The metabolism of N-nitrosobis(2-oxopropyl)amine by microsomes and hepatocytes from Fischer 344 rats. Farrelly JG; Saavedra JE; Kupper RJ; Stewart ML Carcinogenesis; 1987 Aug; 8(8):1095-9. PubMed ID: 3608090 [TBL] [Abstract][Full Text] [Related]
24. Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyl)amine by single intraperitoneal injection on the lung of rats. Yokose Y; Yamamoto K; Nakajima A; Eimoto H; Maruyama H; Mori Y; Konishi Y Jpn J Cancer Res; 1988 Jun; 79(6):698-704. PubMed ID: 3137196 [TBL] [Abstract][Full Text] [Related]
25. Carcinogenic effect of N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine, a postulated proximate pancreatic carcinogen in Syrian hamsters. Pour P; Wallcave L; Gingell R; Nagel D; Lawson T; Salmasi S; Tines S Cancer Res; 1979 Oct; 39(10):3828-33. PubMed ID: 225009 [TBL] [Abstract][Full Text] [Related]
26. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test. Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239 [TBL] [Abstract][Full Text] [Related]
27. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system. Holme JA; Haug LT; Dybing E Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903 [TBL] [Abstract][Full Text] [Related]
28. Metabolic activation capabilities of S9 and hepatocytes from uninduced rats to convert carcinogenic N-nitrosamines to mutagens. Rumruen K; Pool BL Mutat Res; 1984; 140(2-3):147-53. PubMed ID: 6379440 [TBL] [Abstract][Full Text] [Related]
29. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387 [TBL] [Abstract][Full Text] [Related]
30. Alkylation of rodent tissue DNA induced by N-nitrosobis(2-hydroxypropyl)amine. Kokkinakis DM Carcinogenesis; 1992 May; 13(5):759-65. PubMed ID: 1586988 [TBL] [Abstract][Full Text] [Related]
31. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9. Araki A; Muramatsu M; Matsushima T Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472 [TBL] [Abstract][Full Text] [Related]
32. Effect of cigarette smoke on the mutagenic activation of environmental carcinogens by rodent liver. Koide A; Fuwa K; Furukawa F; Hirose M; Nishikawa A; Mori Y Mutat Res; 1999 Jul; 428(1-2):165-76. PubMed ID: 10517990 [TBL] [Abstract][Full Text] [Related]
33. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98. Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118 [TBL] [Abstract][Full Text] [Related]
34. Metabolism and mutagenicity of N-nitroso-2-methoxy-2,6-dimethylmorpholine in hamsters. Gingell R; Brunk G; Nagel D; Wallcave L; Walker B; Pour P J Natl Cancer Inst; 1980 Jan; 64(1):157-61. PubMed ID: 6928040 [TBL] [Abstract][Full Text] [Related]
35. Mutagenicities of N-nitrosamines on Salmonella. Yahagi T; Nagao M; Seino Y; Matsushima T; Sugimura T Mutat Res; 1977 Apr; 48(2):121-9. PubMed ID: 406555 [TBL] [Abstract][Full Text] [Related]
36. Effects of norharman on the mutagenicity of chlorophenylhydroxylamine and its metabolism with rat liver S9. Suzuki J; Kobayashi Y; Monden S; Suzuki S Mutat Res; 1986 Sep; 162(2):165-72. PubMed ID: 3528827 [TBL] [Abstract][Full Text] [Related]
37. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations. Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987 [TBL] [Abstract][Full Text] [Related]
38. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay. Milling DM; Maddock MB Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163 [TBL] [Abstract][Full Text] [Related]
39. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay. Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308 [TBL] [Abstract][Full Text] [Related]
40. Involvement of lauric acid hydroxylase in the activation of beta-substituted nitrosamines. Lawson TA Cancer Lett; 1991 Aug; 59(2):177-82. PubMed ID: 1884375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]